Search

Being a zoonotic parasitic disease, schistosomiasis was widely spread in 12 provinces of Southern China in the 1950s, severly harming human health and hindering economic development. The National Institute of Parasitic Diseases at the Chinese Center for Diseases Control and Prevention, and Chinese Center for Tropical Diseases Research (NIPD-CTDR), as the only professional institution focussing on parasitic diseases at the national level, has played an important role in schistosomiasis control in the country. In this article, we look back at the changes of schistosomiasis endemicity and the contribution of NIPD-CTDR to the national schistosomiasis control programme. We review NIPD-CTDR's activities, including field investigations, design of control strategies and measures, development of diagnostics and drugs, surveillance-response of endemic situation, and monitoringevaluation of the programme. The NIPD-CTDR has mastered the transmission status of schistosomiasis, mapped the snail distribution, and explored strategies and measures suitable for different types of endemic areas in China. With a good understanding of the life cycle of Schistosoma japonicum and transmission patterns of the disease, advanced research carried out in the NIPD-CTDR based on genomics and modern technology has made it possible to explore highly efficient and soft therapeutic drugs and molluscicides, making it possible to develop new diagnostic tools and produce vaccine candidates. In the field, epidemiological studies, updated strategies and targeted intervention measures developed by scientists from the NIPD-CTDR have contributed significantly to the national schistosomiasis control programme. This all adds up to a strong foundation for eliminating schistosomiasis in China in the near future, and recommendations have been put forward how to reach this goal.

Being a zoonotic parasitic disease, schistosomiasis was widely spread in 12 provinces of Southern China in the 1950s, severly harming human health and hindering economic development. The National Institute of Parasitic Diseases at the Chinese Center for Diseases Control and Prevention, and Chinese Center for Tropical Diseases Research (NIPD-CTDR), as the only professional institution focussing on parasitic diseases at the national level, has played an important role in schistosomiasis control in the country. In this article, we look back at the changes of schistosomiasis endemicity and the contribution of NIPD-CTDR to the national schistosomiasis control programme. We review NIPD-CTDR's activities, including field investigations, design of control strategies and measures, development of diagnostics and drugs, surveillance-response of endemic situation, and monitoring & evaluation of the programme. The NIPD-CTDR has mastered the transmission status of schistosomiasis, mapped the snail distribution, and explored strategies and measures suitable for different types of endemic areas in China. With a good understanding of the life cycle of Schistosoma japonicum and transmission patterns of the disease, advanced research carried out in the NIPD-CTDR based on genomics and modern technology has made it possible to explore highly efficient and soft therapeutic drugs and molluscicides, making it possible to develop new diagnostic tools and produce vaccine candidates. In the field, epidemiological studies, updated strategies and targeted intervention measures developed by scientists from the NIPD-CTDR have contributed significantly to the national schistosomiasis control programme. This all adds up to a strong foundation for eliminating schistosomiasis in China in the near future, and recommendations have been put forward how to reach this goal.

Hypertriglyceridaemia is a very rare disorder caused by the mutations of LPL gene, with an autosomal recessive mode of inheritance. Here, we identified two unrelated Chinese patients manifested with severe hypertriglyceridaemia and acute pancreatitis. The clinical symptoms of proband 1 are more severe than proband 2. Whole exome sequencing and Sanger sequencing were performed. Functional analysis of the identified mutations has been done. Whole exome sequencing identified two pairs of variants in LPL gene in the proband 1 (c.162C>A and c.1322+1G>A) and proband 2 (c.835C>G and c.1322+1G>A). The substitution (c.162C>A) leads to the formation of a truncated (p.Cys54*) LPL protein. The substitution (c.835C>G) leads to the replacement of leucine to valine (p.Leu279Val). The splice donor site mutation (c.1322+1G>A) leads to the formation of alternative transcripts with the loss of 134 bp in exon 8 of the LPL gene. The proband 1 and his younger son also harbouring a heterozygous variant (c.553G>T; p.Gly185Cys) in APOA5 gene. The relative expression level of the mutated LPL mRNA (c.162C>A, c.835C>G and c.1322+1G>A) showed significant differences compared to wild-type LPL mRNA, suggesting that all these three mutations affect the transcription of LPL mRNA. These three mutations (c.162C>A, c.835C>G and c.1322+1G>A) showed noticeably decreased LPL activity in cell culture medium but not in cell lysates. Here, we identified three mutations in LPL gene which causes severe hypertriglyceridaemia with acute pancreatitis in Chinese patients. We also described the significance of whole exome sequencing for identifying the candidate gene and disease-causing mutation in patients with severe hypertriglyceridaemia and acute pancreatitis.

Introduction: Plasmodium vivax (Pv) and P. knowlesi account together for a considerable share of the global burden of malaria, along with P. falciparum (Pf). However, inaccurate diagnosis and undetectable asymptomatic/submicroscopic malaria infections remain very challenging. Blood-stage antigens involved in either invasion of red blood cells or sequestration/cytoadherence of parasitized erythrocytes have been immunomics-characterized, and are vital for the detection of malaria incidence. Areas covered: We review the recent advances in Plasmodium immunomics to discuss serological markers with potential for specific and sensitive diagnosis of malaria. Insights on alternative use of immunomics to assess malaria prevalence are also highlighted. Finally, we provide practical applications of serological markers as diagnostics, with an emphasis on dot immunogold filtration assay which holds promise for malaria diagnosis and epidemiological surveys. Expert commentary: The approach largely contributes to Pf and Pv research in identifying promising non-orthologous antigens able to detect malaria incidence and to differentiate between past and recent infections. However, further studies to profiling naturally acquired immune responses are expected in order to help discover/validate serological markers of no cross-seroreactivity and guide control interventions. More so, the application of immunomics to knowlesi infections would help validate the recently identified antigens and contribute to the discovery of additional biomarkers of exposure, immunity, or both.

Background Interventions are currently being used against ‘infectious diseases of poverty’, which remain highly debilitating and deadly in most endemic countries, especially malaria, schistosomiasis, echinococcosis and African sleeping sickness. However, major limitations of current ‘traditional’ methods for diagnosis are neither simple nor convenient for population surveillance, and showed low sensitivity and specificity. Access to novel technologies for the development of adequate and reliable tools are expressly needed. A collaborative project between African Network for Drugs and Diagnostics Innovation and partner institutions in Africa and China aims to screen suitable serological biomarkers for diagnostic pipelines against these ‘diseases of the poor’. Methods Parasite-specific exposed versus unexposed individuals were screened and sera or urine/stools were collected through case-control studies in China and African countries. Target genes/open reading frames were selected, then will be cloned and cell-free expressed, quantified and immuno-detected. Target antigens/epitopes will be probed and screened with sera from exposed or unexposed individuals using a high-throughput antigen screening platform as the study progresses. The specificity and sensitivity of highly immunoreactive biomarkers will be evaluated as well, using enzyme-linked immunosorbent assays or dipsticks. Discussion This roadmap explicitly unfolds the integrated operating procedures with focus on malaria and schistosomiasis, for the identification of suitable biomarkers that will aid the prioritization of diagnostics for population use. However, there is need to further validate any new diagnostic through comparison with standard methods in field deployable tests for each region. Our expectations for the future are to seek regulatory approval and promote the use of diagnostics in endemic areas. Electronic supplementary material The online version of this article (doi:10.1186/s40249-017-0344-9) contains supplementary material, which is available to authorized users.

Based on the FEM analysis of the distributions and varieties of the stresses and the strains of the large-size dissimilar steel welded tube-plate structure under cyclic loading, the fatigue crack initiation sites of this structure were predicted. The low-cycle fatigue test was performed to verify the prediction and to study the cracks propagating paths as well. The results indicated that the weld toes linked to the two surfaces of the plate were the positions with the peak values of the maximum stress and the stress amplitude. The plastic deformations in the first loading cycle introduced the tensile-compressive repeated stress cycle at the weld toes during the subsequent loading cycles. It induced the fatigue cracks initiating at the weld toes linked to the two surfaces of the plate respectively. After initiating from the surfaces the cracks propagated along the fusion lines with a short distance then turn into the base metal in the sections vertical to the surfaces. The depth of the crack initiating from the compressed surface was shorter than the one from the tensioned surface.

To clone and express adenine phosphoribosyltransferase gene of Schistosoma japonicum, and analyze its stage-specific transcription and expression at different developmental stages of S. japonicum.Specific primers were designed according to the reported EST sequence of SjAPRT1 gene (GenBank Accession No. AAW24796). RT-PCR was used to investigate the differential transcription of SjAPRT1 gene during the developmental stages. The gene was cloned into pET28a(+) plasmid. The recombinant plasmid rSjAPRT1/pET28a(+) was transformed into E. coli BL21(DE3) and induced with IPTG. The recombinant protein was purified with Ni-NTA resin and analyzed by SDS-PAGE. The purified protein was used to immune New Zealand white rabbits to obtain the antiserum. Western blotting was used to investigate the immunogenicity and the differential expression of rSjAPRT1 at different developmental stages.RT-PCR result showed that the specific bands were detected in eggs, cercariae, schistosomula, and adult worms (561 bp). Western blotting analysis showed that the recombinant protein (rSjAPRT1, about Mr 25 000) existed in eggs, schistosomula and adult worms. The recombinant protein was recognized by pooled sera of infected rabbits.The recombinant protein (rSjAPRT1) shows specific immunoreactivity, and is detected in the stage of eggs, schistosomula, and adult worms.

To clone and express endothelial differentiation-related factor (SjEDF)-1 gene of Schistosoma japonicum, analyze its immunogenicity and the stage-specific expression at different developmental stages of S. japonicum.Total RNA were extracted from eggs, cercariae, schistosomula and adult worms. The housekeeping gene SjActin was selected as the internal reference. According to the open reading frame for SjEDF-1 gene (GenBank accession number: AY336498), a pair of primers were designed to amplify the SjEDF-1 gene which was subcloned into pET-28a vector. The recombinant plasmid SjEDF-1/pET-28a was transformed into E. coli BL21 and induced with IPTG for expression. The recombinant protein was purified with Ni-NTA resin. The immune rabbit sera was prepared by immunizing New Zealand white rabbits with purified recombinant SjEDF-1 protein. Western blotting was used to analyze the immunogenicity and the expression level of SjEDF-1 at the different developmental stages.The SjEDF-1 gene was detected with a band of 405 bp in eggs, schistosomula, female and male worms. The recombinant protein (rSjEDF-I) was expressed as inclusion bodies (M, 20 000). Western blotting analysis showed that the purified rSjEDF-1 protein was recognized by pooled sera of infected rabbits. The target protein was detected only in schistosomulum and adult worms.The recombinant protein (rSjEDF-I) shows certain immunogenicity, and is detected only in schistosomula and adult worms.